论文信息 - A Phase 1 Study of XmAb18968, a CD3-CD38 Bispecific Antibody for the Treatment of Patients with Relapsed/Refractory Acute Leukemia and T Cell Lymphoblastic Lymphoma - 字舞流文

A Phase 1 Study of XmAb18968, a CD3-CD38 Bispecific Antibody for the Treatment of Patients with Relapsed/Refractory Acute Leukemia and T Cell Lymphoblastic Lymphoma

K. Aoki | W. Stock | K. Pratz | S. Yaghoubi | A. Szabo | B. Shah | S. Luger | W. Cui | A. Harrington | L. Michaelis | K. Carlson | K. Hoffmeister | E. Atallah | T. Badar | J. Leonard | S. Abedin | Tyce J. Kearl | G. S. Guru Murthy | A. Baim | A. DuVall | L. Runaas | Bryon D. Johnson